Canlyniadau Chwilio - David A. Cox
- Dangos 1 - 20 canlyniadau o 58
- Ewch i'r Dudalen Nesaf
-
1
-
2
-
3
Risk-Benefit Profile for Raloxifene: 4-Year Data From the Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial gan Elizabeth Barrett‐Connor, Jane A. Cauley, Pandurang M. Kulkarni, Andreas Sashegyi, David A. Cox, Mary Jane Geiger
Cyhoeddwyd 2004Artigo -
4
-
5
A Global Study of Vitamin D Status and Parathyroid Function in Postmenopausal Women with Osteoporosis: Baseline Data from the Multiple Outcomes of Raloxifene Evaluation Clinical Tr... gan Paul Lips, T.A. Duong, Anna Oleksik, Dennis M. Black, Steven R. Cummings, David A. Cox, Thomas Nickelsen
Cyhoeddwyd 2001Artigo -
6
The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled Trial1 gan Brian W. Walsh, Sofia Paul, Robert A. Wild, Robert A. Dean, Russell P. Tracy, David A. Cox, Pamela W. Anderson
Cyhoeddwyd 2000Artigo -
7
-
8
-
9
-
10
-
11
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11) gan Juan P. Frías, Enzo Bonora, Luis Nevárez Ruiz, Ying G. Li, Zhuoxin Yu, Zvonko Miličević, Raleigh Malik, M. Angelyn Bethel, David A. Cox
Cyhoeddwyd 2021Artigo -
12
Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention gan Rajendra H. Mehta, Kishore J. Harjai, David A. Cox, Gregg W. Stone, Bruce R. Brodie, Judy Boura, William W. O’Neill, Cindy L. Grines
Cyhoeddwyd 2003Artigo -
13
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of <scp>AWARD</scp>‐11 gan Enzo Bonora, Juan P. Frías, Francisco J. Tinahones, Joanna Van, Raleigh Malik, Zhuoxin Yu, Reema Mody, Angelyn Bethel, Anita Y. M. Kwan, David A. Cox
Cyhoeddwyd 2021Artigo -
14
-
15
Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes gan Silva Arslanian, Tamara S. Hannon, Philip Zeitler, Lily C. Chao, Claudia Boucher‐Berry, Margarita Barrientos‐Pérez, Élise Bismuth, Sérgio Atala Dib, Jang Ik Cho, David A. Cox
Cyhoeddwyd 2022Artigo -
16
A comparative analysis of primary stenting and optimal balloon coronary angioplasty in acute myocardial infarction. Six month results from the STENT PAMI trial gan Luiz Alberto Mattos, Cindy L. Grines, David A. Cox, J. Eduardo Sousa, Costantino Costantini, Gregg W. Stone, Marie Claude Morice, William W. O’Neill, Eulogio Garcı́a, Judith Boura
Cyhoeddwyd 2000Artigo -
17
Rheolytic Thrombectomy With Percutaneous Coronary Intervention for Infarct Size Reduction in Acute Myocardial Infarction gan Ali Arshad, David A. Cox, Nabil Dib, Bruce R. Brodie, Daniel S. Berman, Navin Gupta, Kevin F. Browne, Robert Iwaoka, Michael Azrin, Dwight Stapleton, Cindy Setum, Jeffrey J. Popma
Cyhoeddwyd 2006Artigo -
18
Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction gan Gregg W. Stone, David A. Cox, Eulogio Garcı́a, Bruce R. Brodie, Marie‐Claude Morice, John J. Griffin, Luiz Alberto Mattos, Alexandra J. Lansky, William W. O’Neill, Cindy L. Grines
Cyhoeddwyd 2001Artigo -
19
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease gan Gregg W. Stone, Stephen G. Ellis, David A. Cox, James Hermiller, Charles O’Shaughnessy, J. Tift Mann, Mark Turco, Ronald Caputo, Patrick Bergin, Joel Greenberg, Jeffrey J. Popma, Mary E. Russell
Cyhoeddwyd 2004Artigo -
20
A community study in Cornwall UK of sudden unexpected death in epilepsy (SUDEP) in a 9-year population sample gan Rohit Shankar, Virupakshi Jalihal, Matthew C. Walker, Richard Laugharne, Brendan McLean, Emma Carlyon, Jane Hanna, Stephen L. Brown, Caryn Jory, Mike Tripp, Adrian Pace, David A. Cox, Scott W. Brown
Cyhoeddwyd 2014Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Internal medicine
Cardiology
Myocardial infarction
Percutaneous coronary intervention
Revascularization
Angioplasty
Randomized controlled trial
Stent
Surgery
Confidence interval
Restenosis
Conventional PCI
Acute coronary syndrome
Endocrinology
Abciximab
Coronary artery disease
Environmental health
Hazard ratio
Population
Radiology
Thrombolysis
Alternative medicine
Artery
Chemotherapy
Clinical endpoint
Diabetes mellitus
Drug-eluting stent
Heart failure
Paclitaxel